Reata Pharmaceuticals Investor Relations Material
Latest events
Q1 2023
Reata Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Reata Pharmaceuticals Inc
Access all reports
Reata Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies for serious or life-threatening diseases. The company specializes in small-molecule therapeutics targeting molecular pathways involved in oxidative stress and inflammation. The company is headquartered in Plano, Texas, and its shares are listed on the NASDAQ.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
RETA
Country
πΊπΈ United States